Back
Agios Pharmaceuticals Quote, Financials, Valuation and Earnings
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
42
AGIO
Agios Pharmaceuticals
Last Price:
46.64
Seasonality Move:
7.84%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Agios Pharmaceuticals Price Quote
$46.64
-0.06 (4.15%)
(Updated: November 6, 2024 at 4:57 AM ET)
Agios Pharmaceuticals Key Stats
Sell
42
Agios Pharmaceuticals (AGIO)
is a Sell
Day range:
$43.25 - $46.79
52-week range:
$20.40 - $53.29
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
80.82
P/B ratio:
1.64%
Volume:
996K
Avg. volume:
601.4K
1-year change:
107.65%
Market cap:
$2.7B
Revenue:
$26.8M
EPS:
$11.36
How Much Does Agios Pharmaceuticals Make?
-
How Much Are Agios Pharmaceuticals's Sales Annually?
AGIO Revenues are $26.8M -
How Much Profit Does Agios Pharmaceuticals's Make A Year?
AGIO net income is -$352.1M
Is Agios Pharmaceuticals Growing As A Company?
-
What Is Agios Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.21% -
What Is Agios Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Agios Pharmaceuticals Stock Price Performance
-
Did Agios Pharmaceuticals Stock Go Up Last Month?
Agios Pharmaceuticals share price went up by 13.01% last month -
Did AGIO's Share Price Rise Over The Last Year?
AGIO share price rose by 107.65% over the past 1 year
What Is Agios Pharmaceuticals 52-Week High & Low?
-
What Is Agios Pharmaceuticals’s 52-Week High Share Price?
Agios Pharmaceuticals has traded as high as $53.29 over the past 52 weeks -
What Is Agios Pharmaceuticals’s 52-Week Low Share Price?
Agios Pharmaceuticals has traded as low as $20.40 over the past 52 weeks
Agios Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Agios Pharmaceuticals?
-
How Much Debt Does Agios Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Agios Pharmaceuticals Have?
Cash and short term investments quarterly total is $1B -
What Is Agios Pharmaceuticals’s Book Value Per Share?
Book value per share is 28.53
Is Agios Pharmaceuticals Cash Flow Positive?
-
What Is AGIO Cash Flow From Operations?
Cash flow from operations (TTM) is -$329.2M -
What Is Agios Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $10.4M -
What Is Agios Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $508.1M
Agios Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
AGIO return on invested capital is 71.3% -
What Is Agios Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 62.91% -
What Is AGIO Return On Equity?
ROE is a measure of profitability and is 71.3%
Agios Pharmaceuticals Earnings Date & Stock Price
-
What Is Agios Pharmaceuticals's Stock Price Today?
A single share of AGIO can be purchased today for 46.70 -
What Is Agios Pharmaceuticals’s Stock Symbol?
Agios Pharmaceuticals trades on the nasdaq under the ticker symbol: AGIO -
When Is Agios Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Agios Pharmaceuticals is scheduled on February 14, 2025 -
When Is AGIO's next ex-dividend date?
Agios Pharmaceuticals's next ex-dividend date is June 4, 2020 -
How To Buy Agios Pharmaceuticals Stock?
You can buy Agios Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Agios Pharmaceuticals Competitors
-
Who Are Agios Pharmaceuticals's Competitors?
Below is a list of companies who compete with Agios Pharmaceuticals or are related in some way:
Agios Pharmaceuticals Dividend Yield
-
What Is AGIO Dividend Yield?
Agios Pharmaceuticals’s dividend yield currently is 0% -
What Is Agios Pharmaceuticals’s Payout Ratio?
Agios Pharmaceuticals’s payout ratio is 0% -
When Did Agios Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is Agios Pharmaceuticals’s Dividend Per Share?
Agios Pharmaceuticals pays a dividend of $0.00 per share
Agios Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -118.52% |
| Revenue: | 21.15% | -5.66% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 53.88 |
| Upside from Last Price: | 15.36% |